197 related articles for article (PubMed ID: 31129500)
1. Synthesis, biological evaluation and molecular docking studies of novel 3,5-disubstituted 2,4-thiazolidinediones derivatives.
Ranjan Srivastava A; Bhatia R; Chawla P
Bioorg Chem; 2019 Aug; 89():102993. PubMed ID: 31129500
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Naim MJ; Alam O; Alam MJ; Shaquiquzzaman M; Alam MM; Naidu VGM
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700223. PubMed ID: 29400412
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
Shukla S; Kumar P; Das N; Moorthy NS; Shrivastava SK; Trivedi P; Srivastava RS
Med Chem; 2012 Sep; 8(5):834-45. PubMed ID: 22741802
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives.
Naim MJ; Alam MJ; Nawaz F; Naidu VGM; Aaghaz S; Sahu M; Siddiqui N; Alam O
Bioorg Chem; 2017 Aug; 73():24-36. PubMed ID: 28582649
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists.
Nazreen S; Alam MS; Hamid H; Shahar Yar M; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai K
Arch Pharm (Weinheim); 2015 Jun; 348(6):421-32. PubMed ID: 25900064
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
Shakour N; Sahebkar A; Karimi G; Paseban M; Tasbandi A; Mosaffa F; Tayarani-Najaran Z; Ghodsi R; Hadizadeh F
Bioorg Chem; 2021 Oct; 115():105162. PubMed ID: 34314919
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression.
Nazreen S; Alam MS; Hamid H; Yar MS; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Kharbanda C; Ali Y; Pillai KK
Bioorg Med Chem Lett; 2014 Jul; 24(14):3034-42. PubMed ID: 24890090
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
Bansal G; Singh S; Monga V; Thanikachalam PV; Chawla P
Bioorg Chem; 2019 Nov; 92():103271. PubMed ID: 31536952
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents.
Naim MJ; Alam O; Alam MJ; Hassan MQ; Siddiqui N; Naidu VGM; Alam MI
Bioorg Chem; 2018 Feb; 76():98-112. PubMed ID: 29169079
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in-vitro α-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives.
Hussain F; Khan Z; Jan MS; Ahmad S; Ahmad A; Rashid U; Ullah F; Ayaz M; Sadiq A
Bioorg Chem; 2019 Oct; 91():103128. PubMed ID: 31369977
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, ADME, docking studies and in vivo anti-hyperglycaemic potential estimation of novel Schiff base derivatives from octadec-9-enoic acid.
Kapoor G; Pathak DP; Bhutani R; Husain A; Jain S; Iqbal MA
Bioorg Chem; 2019 Mar; 84():478-492. PubMed ID: 30579158
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Molecular Docking Studies of Novel Thiadiazole Analogues with Potential Antimicrobial and Antiinflammatory Activities.
Mehta DK; Taya P; Das R; Dua K
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):91-109. PubMed ID: 30848217
[TBL] [Abstract][Full Text] [Related]
15. A convenient approach to synthesize substituted 5-Arylidene-3-m-tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study.
Jahan K; Khan KR; Akhter K; Romman UKR; Halim E
PLoS One; 2021; 16(3):e0247619. PubMed ID: 33661961
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinedione Derivatives: In Silico, In Vitro, In Vivo, Antioxidant and Anti-Diabetic Evaluation.
Sameeh MY; Khowdiary MM; Nassar HS; Abdelall MM; Amer HH; Hamed A; Elhenawy AA
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164095
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4(3H)-one derivatives as potential PPARγ and SUR agonists.
Ibrahim MK; Eissa IH; Alesawy MS; Metwaly AM; Radwan MM; ElSohly MA
Bioorg Med Chem; 2017 Sep; 25(17):4723-4744. PubMed ID: 28720328
[TBL] [Abstract][Full Text] [Related]
18. Biocatalytic one pot three component approach: Facile synthesis, characterization, molecular modelling and hypoglycemic studies of new thiazolidinedione festooned quinoline analogues catalyzed by alkaline protease from Aspergillus niger.
Angajala G; Aruna V; Pavan P; Guruprasad Reddy P
Bioorg Chem; 2022 Feb; 119():105533. PubMed ID: 34902647
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists.
Nazreen S; Alam MS; Hamid H; Yar MS; Shafi S; Dhulap A; Alam P; Pasha MA; Bano S; Alam MM; Haider S; Ali Y; Kharbanda C; Pillai KK
Eur J Med Chem; 2014 Nov; 87():175-85. PubMed ID: 25255433
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of sulpha drug based hydroxytriazene derivatives: Anti-diabetic, antioxidant, anti-inflammatory activity and their molecular docking studies.
Sharma P; Dayma V; Dwivedi A; Baroliya PK; Tripathi IP; Vanangamudi M; Chauhan RS; Goswami AK
Bioorg Chem; 2020 Mar; 96():103642. PubMed ID: 32062065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
